New 23andMe product nears as it lands $115M funding, unicorn valuation

Genetic-testing company 23andMe Inc. said on Wednesday it raised $115 million in Series E funding to help it launch a new consumer product and expand its drug-discovery arm...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.